Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118524) titled 'A Prospective Randomized Controlled Study of Irreversible Electroporation for Low-to-Intermediate -Risk Localized Prostate Cancer Guided by Electromagnetic Navigation and AI-Assisted Image Fusion' on Feb. 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chinese PLA General Hospital
Condition:
Prostate cancer
Intervention:
Group A:IRE Guided by Traditional Cognitive Fusion
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-06
Target Sample Size: Group A:55;Group B:55;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...